2.10.17, Novel method for time-resolved RNA sequencing by the Ameres Lab
SLAMseq is an innovative sequencing method developed by the Ameres Lab (IMBA) in collaboration with Arndt von Haeseler’s group (CIBIV/MFPL) and other researchers at the Vienna Biocenters. This novel technology opens up new possibilities for medical screening and testing medication on live cells, as reported in the journal Nature Methods. The Viennese RNA community congratulates its members to their work:
Thiol-linked alkylation of RNA to assess expression dynamics.
This work is an outstanding example for a very fruitful basic research—biotech success story: Based on this research, a kit for metabolic sequencing of RNA will now be marketed worldwide by bioetch company Lexogen! See the IMBA news about this: SLAMseq to be marketed worldwide.
Here a glimpse of how the Ameres Lab celebrated this success: